0000950170-25-105948
SEC filingRevenue declined 1% QoQ to $51.6M, driven by a 43% drop in contract revenue, partially offset by product revenue growth.
For the three months ended June 30, 2025, total revenue was $51.6 million, a decrease of $0.7 million or 1% compared to $52.4 million in the same period of 2024. The decline was primarily driven by a $1.4 million decrease in contract revenue, partially offset by a $0.7 million increase in product revenue. Product revenue growth was attributed to a favorable product mix, though volume and average selling price declined. Contract revenue fell due to the wind-down of a large multi-year non-recurring engineering project that began in early 2022.
Gross profit decreased to $20.9 million (40.6% of revenue) from $22.1 million (42.2% of revenue) in the prior year, reflecting a 160 bps margin contraction. The decline was driven by a $0.5 million increase in cost of goods sold, primarily from product mix changes, partially offset by lower volumes.
Operating expenses totaled $94.6 million, up 6% from $89.0 million. Research and development expense decreased 7% to $38.5 million, reflecting a $2.6 million reduction in program costs and a $2.4 million decrease in personnel costs from restructuring, partially offset by a $1.6 million increase in share-based compensation. Selling, general and administrative expense increased 5% to $18.4 million, driven by a $1.0 million rise in share-based compensation. Restructuring costs of $7.1 million were incurred in the current quarter under the May 2025 Restructuring Plan.
Net loss for the quarter was not explicitly stated for the three-month period, but for the six months ended June 30, 2025, net loss was $78.8 million compared to $55.2 million in the prior year, a 43% increase. The higher loss was driven by a $13.8 million decrease in other income, net, primarily due to a $17.2 million decline in gains from fair value changes of contingent considerations, partially offset by a $2.6 million gain from debt extinguishment.
The company reports two revenue segments: product revenue and contract revenue. Product revenue, which represented 96% of total revenue in Q2 2025 (up from 94% in Q2 2024), grew 1% YoY to $49.7 million. The growth was driven by product mix improvements, though volume and ASP declined. Contract revenue, representing 4% of total revenue, fell 43% to $1.9 million as the large NRE project nears completion. The shift toward product revenue reflects the company's core semiconductor business, while contract revenue is expected to continue declining as the project winds down.
Management expects research and development expense to stabilize over time, following the restructuring actions in August 2024 and May 2025. Selling, general and administrative expense is also expected to stabilize. The company believes its current liquidity sources—cash, cash equivalents, anticipated operating cash flows, and available borrowings under its revolving credit facility and ATM program—will be sufficient for at least the next 12 months. However, future capital requirements depend on sales growth, business initiatives, M&A, international expansion, new product introductions, and macroeconomic conditions including tariffs and geopolitical tensions. The company continues to evaluate options to mitigate tariff impacts.
As of June 30, 2025, indie Semiconductor reported cash and cash equivalents of $192.6 million and restricted cash of $10.3 million. Total debt stood at $352.5 million, comprising $130 million of 4.50% convertible notes due 2027 (net carrying $127.8 million after discount), $218.5 million of 3.50% convertible notes due 2029 (net $210.4 million), a $1.8 million CIBC loan, and a $12.5 million revolving line of credit. Stockholders' equity was $415.1 million, with a noncontrolling interest of $24.7 million. Inventory of $47.0 million reflects a reduction from $49.9 million at year-end 2024. Deferred revenue (contract liabilities) was $3.3 million.
No material purchase commitments were disclosed in the notes beyond routine royalty agreements. The company has royalty obligations under technology licenses, with $0.6 million and $1.3 million expensed in Q2 and H1 2025, respectively. There are no off-balance-sheet arrangements or significant capital commitments. The company has a repurchase authorization for Class A common stock with $42.6 million remaining, but no shares were repurchased in the current period.
Indie Semiconductor repurchased $30 million aggregate principal of its 2027 convertible notes in June 2025 at a discount, recognizing a pre-tax gain of $2.6 million. No new debt was issued, and no dividends were paid. The company maintains a $50 million stock repurchase program, with $42.6 million still authorized. Capital expenditures (not explicitly in notes but from cash flow statement) were $8.4 million in H1 2025, funded from operating cash flows.
The company operates as a single reportable segment (Note 18). Geographic revenue data (Note 12) shows H1 2025 revenue of $105.7 million, with Greater China contributing 39%, Europe 23%, United States 16%, and Rest of Asia Pacific 12%. No individual customer exceeded 10% of revenue. The company’s long-lived assets are concentrated in the U.S. and Europe.
Net loss widened to $78.8M from $55.2M, while operating cash outflow increased to $36.6M from $29.1M. The primary non-cash adjustments were share-based compensation ($32.2M) and depreciation/amortization ($20.2M). Working capital changes consumed cash, notably accounts receivable ($5.6M use) and accounts payable ($8.9M use), partially offset by inventory reduction ($4.2M source).
Capital expenditures of $8.4M exceeded prior year's $6.0M, representing a 40% increase. No free cash flow is explicitly stated, but CFO of -$36.6M and capex of $8.4M imply negative free cash flow.
No dividends or share repurchases were reported. Financing activities were dominated by $26.8M in debt repurchases, contributing to the $34.0M net cash used in financing.
A $4.9M gain from change in fair value of contingent considerations and a $2.6M gain from debt extinguishment provided non-cash boosts to net loss reconciliation. The effect of exchange rates reduced cash by $2.7M.